Kansas State University
Manhattan, Kansas, 66506, United States
NCT Number: NCT02185872
The purpose of this study was to examine the differences in glucose control, fitness, and body composition between a standard aerobic and resistance exercise training program and a shorter-duration, high-intensity CrossFit training program in overweight and obese physically inactive adults.
Hypotheses:
1. Both groups would improve glucose control, with the CrossFit group improving significantly more than the aerobic and resistance training group. 2. Both groups would improve fitness, with the CrossFit group improving significantly more than the aerobic and resistance training group. 3. Both groups would demonstrate decreases in body fat percentage and fat mass and increases in lean body mass, with the CrossFit group improving significantly more than the aerobic and resistance training group.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Manhattan, Kansas, 66506, United States
Overweight or obese participants will take part in an 8-week exercise intervention after clearance from a doctor, that is expected to improve glucose control, fitness (Eurofit and peak aerobic capacity), and body composition (body fat percentage, fat mass, and lean body mass). After stratification by age and body mass index, participants will be randomized to either a standard aerobic and resistance training exercise program or a relatively higher intensity, shorter duration CrossFit exercise program.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants were instructed to work as hard as they could while maintaining safe technique and proper form to achieve as many reps or rounds as possible in the prescribed time frame. As HIFT participants became accustomed to specific movements, less time was dedicated to practicing movements and technique.
Other names: CrossFit
The protocol was based upon current guidelines of 150 minutes moderate-intensity aerobic activity and 2 days of muscle strengthening per week.
Time frame: Baseline, Week 10
Fasting plasma glucose levels were taken after an overnight fast of at least 8 hours. An oral glucose tolerance test was conducted after ingestion of a 75g oral dextrose solution with finger sticks at 30, 45, and 60 minutes from time 0. The following equation was used to calculate glucose area under the curve which was the metric utilized to ascertain changes in glucose control: [(Time 45 - Time 30) * ½ (OGTT 30 + OGTT 45)] + [(Time 60 - Time 45) * ½ (OGTT 60 + OGTT 45)]
Time frame: Baseline, Week 10
Modified Balke protocol
Time frame: Baseline, Week 10
Eurofit protocol for sit and reach distance using flex tester box
Time frame: Baseline, Week 10
Eurofit protocol
Time frame: Baseline, Week 10
Eurofit protocol
Time frame: Baseline, Week 10
Eurofit protocol; completed on feet or knees
Time frame: Baseline, Week 10
Eurofit protocol
Time frame: Baseline, Week 10
A handheld stopwatch was used to record time from the command "Go" until the participant crossed the line at 40 meters
Time frame: Baseline, Week 10
Time frame: Baseline, Week 12
Dual X-ray absorptiometry scan was used to assess body fat percentage, lean body mass, and fat mass.
Time frame: 24 exercise sessions over 8 weeks
Time spent to complete each assigned daily workout was individually recorded for each participant
Kansas State University
Other
The Influence of a CrossFit Exercise Program on Glucose Control in Overweight and Obese Individuals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06125704
Behavior, Circadian Rhythm
Knoxville, Tennessee, United States
View Trial DetailsNCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT05343494
Behavior, Diabetes Mellitus
New Orleans, Louisiana, United States
View Trial DetailsNCT03651713
Behavior, Endothelial Function
Iowa City, Iowa, United States
View Trial Details